Literature DB >> 28040987

Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?

Hemang Yadav1, B Taylor Thompson2, Ognjen Gajic1.   

Abstract

Despite significant advances in our understanding and management of patients with acute respiratory distress syndrome (ARDS), the morbidity and mortality from ARDS remains high. Given the limited number of effective treatments for established ARDS, the strategic focus of ARDS research has shifted toward identifying patients with or at high risk of ARDS early in the course of the underlying illness, when strategies to reduce the development and progression of ARDS and associated organ failures can be systematically evaluated. In this review, we summarize the rationale, current evidence, and future directions in ARDS prevention.

Entities:  

Keywords:  acute lung injury; acute respiratory distress syndrome; prevention; respiratory failure

Mesh:

Year:  2017        PMID: 28040987     DOI: 10.1164/rccm.201609-1767CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Generalizable Biomarkers in Critical Care: Toward Precision Medicine.

Authors:  Timothy E Sweeney; Purvesh Khatri
Journal:  Crit Care Med       Date:  2017-06       Impact factor: 7.598

Review 2.  Inhalation therapies in acute respiratory distress syndrome.

Authors:  Antonio Artigas; Marta Camprubí-Rimblas; Neus Tantinyà; Josep Bringué; Raquel Guillamat-Prats; Michael A Matthay
Journal:  Ann Transl Med       Date:  2017-07

Review 3.  Extracorporeal membrane oxygenation as rescue therapy for severe hypoxemic respiratory failure.

Authors:  Bhoumesh Patel; Subhasis Chatterjee; Seanna Davignon; J Patrick Herlihy
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury.

Authors:  Sean P Nassoiy; Favin S Babu; Heather M LaPorte; Matthias Majetschak
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09-20       Impact factor: 2.557

5.  Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β2 -adrenergic receptor.

Authors:  Thomas C Rich; Silas J Leavesley; Angela P Brandon; Cilina A Evans; S Vamsee Raju; Brant M Wagener
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

Review 6.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

7.  An analysis of the 28-day mortality risk factors in acute respiratory distress syndrome patients and the establishment of prediction models.

Authors:  Hui Chen; Qiong Liu; Lifeng Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  RAB26-dependent autophagy protects adherens junctional integrity in acute lung injury.

Authors:  Weijie Dong; Binfeng He; Hang Qian; Qian Liu; Dong Wang; Jin Li; Zhenghua Wei; Zi Wang; Zhi Xu; Guangyu Wu; Guisheng Qian; Guansong Wang
Journal:  Autophagy       Date:  2018-07-26       Impact factor: 16.016

9.  Early Intravascular Events Are Associated with Development of Acute Respiratory Distress Syndrome. A Substudy of the LIPS-A Clinical Trial.

Authors:  Raja-Elie E Abdulnour; Tina Gunderson; Ioanna Barkas; Jack Y Timmons; Cindy Barnig; Michelle Gong; Daryl J Kor; Ognjen Gajic; Daniel Talmor; Rickey E Carter; Bruce D Levy
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 30.528

10.  Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review.

Authors:  Xiaobo Chen; Feng Wang; Zhiwei Huang; Yan Wu; Jie Geng; Yuliang Wang
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.